Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Experimental Hematology ; (6): 368-372, 2009.
Article in Chinese | WPRIM | ID: wpr-302131

ABSTRACT

The aim of this study was to investigate the bcl-2/IgH expression levels in patients with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) and its clinical significance. The bcl-2/IgH expression levels in bone marrow (BM) and/or peripheral blood (PB) of 20 patients were detected by using SYBR Green I real-time polymerase chain reaction, and the dynamic monitoring for bcl-2/IgH expression level in 4 of these patients was performed. The results showed that in patients with bcl-2/IgH-positive there was no statistically significant difference in the relative copy-numbers of bcl-2/IgH fusion gene in BM and PB (4.23 and 2.73 respectively, p = 0.107), but the difference was significant before and after treatment (3.61 and 2.69 respectively, p = 0.000), the expression level of bcl-2/IgH fusion gene in newly diagnosed and relapsed group was remarkably higher than that in remission group (p = 0.008). The bcl-2/IgH expression level in PB increased evidently 3 months prior to the clinical relapse in one case out of dynamically monitored 4 cases. It is concluded that the bcl-2/IgH expression level is associated with the disease status, the expression level is high in newly diagnosed and relapsed patients and low in those who achieved remission, the bcl-2/IgH fusion gene expression level decreased evidently after therapy, this change may be related to the clinical disease progression, the results suggest that peripheral blood can be regarded as the resource for detection of bcl-2/IgH fusion gene.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Gene Expression , Genes, Immunoglobulin Heavy Chain , Genes, bcl-2 , Lymphoma , Genetics , Oncogene Proteins, Fusion , Genetics , Polymerase Chain Reaction , Methods , Translocation, Genetic
2.
China Journal of Chinese Materia Medica ; (24): 2326-2331, 2007.
Article in Chinese | WPRIM | ID: wpr-324354

ABSTRACT

With the fast development of medicinal animals as new drugs, research on Periplaneta americana become hot recently. Several drugs which mainly consisted of P. americana were approved for clinical applications. The chemical constituents and pharmacological bioactivities of this insect were summarized herein, which provides informativon for further researches on this medicinal animal.


Subject(s)
Animals , Amino Acids , Pharmacology , Anti-Bacterial Agents , Pharmacology , Antineoplastic Agents , Pharmacology , Cardiotonic Agents , Pharmacology , Cycloparaffins , Pharmacology , Materia Medica , Pharmacology , Molecular Structure , Neuropeptides , Pharmacology , Periplaneta , Chemistry
SELECTION OF CITATIONS
SEARCH DETAIL